As shown in Figure 7a, only 0.3% of patients with HCC had the gene amplification of SAE1 and no alteration was observed in the remaining 99.7% of patients, according to the analysis across 6 HCC cohorts in the cBioPortal database. This evidence concerns the gene SAE1 and hepatocellular carcinoma.